Stonepine Capital Management LLC recently announced the acquisition of new stake in Gamida Cell Ltd (NASDAQ:GMDA). The institutional investor has increased its shareholding in the Healthcare company by 431.06% to 7.97 million shares with purchase of 6.47 million shares. This fresh investment now brings its stake to 6.01% valued currently at $3.29 million. In addition, Nantahala Capital Management LLC raised its holdings by 4.33 million to 4.33 million shares. And Levin Capital Strategies LP has lifted its position by 1.47% or 39000.0 shares – to 2.69 million shares.
Currently, there are 132.64M common shares owned by the public and among those 120.05M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 23 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 23 of these insider trades were purchases, accounting for 1,044,083 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The top 3 mutual fund holders in Gamida Cell Ltd are Fidelity VIP – Growth Portfolio, Fidelity Capital Appreciation Fun, and ARK Israel Innovative Technology. Fidelity VIP – Growth Portfolio owns 2.21 million shares of the company’s stock, all valued at over $0.91 million. ARK Israel Innovative Technology now owns shares totaling to 1.62% of the shares outstanding.
However, the script later moved the day high at 0.3537, up 10.11%. The company’s stock has a 5-day price change of 16.07% and -61.16% over the past three months. GMDA shares are trading -24.23% year to date (YTD), with the 12-month market performance down to -79.69% lower. It has a 12-month low price of $0.22 and touched a high of $2.51 over the same period. GMDA has an average intraday trading volume of 2.97 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.15%, -7.96%, and -72.26% respectively.
Institutional ownership of Gamida Cell Ltd (NASDAQ: GMDA) shares accounts for 31.80% of the company’s 132.64M shares outstanding. Mutual fund holders own 5.52%, while other institutional holders and individual stakeholders account for 8.38% and 18.14% respectively.
It has a market capitalization of $41.48M and a beta (3y monthly) value of 1.04. The earnings-per-share (ttm) stands at -$0.90. Price movements for the stock have been influenced by the stock’s volatility, which stands at 15.43% over the week and 13.09% over the month.
Analysts forecast that Gamida Cell Ltd (GMDA) will achieve an EPS of -$0.15 for the current quarter, -$0.13 for the next quarter and -$0.56 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.19 while analysts give the company a high EPS estimate of -$0.13. Comparatively, EPS for the current quarter was -$0.3 a year ago. Earnings per share for the fiscal year are expected to increase by 37.90%, and 27.27% over the next financial year.
Looking at the support for the GMDA, a number of firms have released research notes about the stock. Alliance Global Partners stated their Buy rating for the stock in a research note on November 01, 2021, with the firm’s price target at $11.
